您好,欢迎来到上海士研管理咨询有限公司
士研峰会 士研智库 士研调研
嘉宾信息
发布时间: 2019 - 09 - 23
点击次数: 0
所属职位: Executive Vice President | Chief Operating Officer
所属公司: Medivir AB
个人简介:
Dr. Herder is Executive Vice President, Chief Operating Officer in Medivir AB (Stockholm,Sweden)and has been responsible for business development since 2017.She has more than 25years of experience in drug development as well as business development in the pharmaceuticalindustry. Prior to joining Medivir, Christina was the CEO of Modus Therapeutics, a Swedish drugdevelopment company. Since 2015 she has been a member of the Board of PCI BiotechHolding ASA (listed on Oslo Stock Exchange). Previous assignments include several seniorroles in Swedish Orphan Biovitrum (Sobi), Biovitrumas well as Pharmacia.Christina Herder holdsa doctorate from the Royal Institute of Technology in Stockholm and an Executive MBA fromStockholm University.
发布时间: 2019 - 09 - 23
点击次数: 0
所属职位: 首席执行官
所属公司: Bionetix Inc.
个人简介:
Dr. Doo Young Jung is a founder and CEO of Bionetix, Inc. Dr. Jung has founded Bionetix,Inc. in February 2017. After receiving his Ph. D. degree in organic chemistry, Dr. Jung hasdeveloped good skills of intellectual property and business development for biotech industry.Dr. Jung had worked as a former patent examiner at Korea Intellectual Property Office from2010 to 2012 and had been the Business Development head at Korea Research Institute ofChemical Technology, a Korean government funded research institute from 2013, where hehad successfully participated in several out-licensing deals with global pharmas andbiotechs. In February 2017, he has teamed up with Dr. Jin-Soo Lee, CTO of Bionetix and aformer head of R&D at Dongwha Pharmaceutical Company of Korea, and with Dr. HyunyongCho, COO of Bionetix, and a former VP at Heraeus Korea to found Bionetix, Inc.
发布时间: 2019 - 09 - 23
点击次数: 0
所属职位: 首席执行官
所属公司: bBHC-STRI
个人简介:
bBHC is life science company. We world’s first developed pluripotent stem cells without sideeffects which is called nEPS. Also we successfully differentiated nEPS into human pancreaticbeta cell, hepatocyte, neurocyte, chondrocyte, osteoblast, kidney cell and T-cell.bBHC is corporation to develop human tissues and organs.
发布时间: 2019 - 09 - 23
点击次数: 0
所属职位: 执行董事
所属公司: 资元堂生物科技股份有限公司
个人简介:
专长于生物化学、分子微生物学与生化工程,参与基因编辑技术建立与基因工程微生物生产特用化学品技术开发。于2018年加入资元堂生物科技股份有限公司。负责发展策略策划与拟定,并参与GYT-088灵长类动物模型先导试验。
微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务